Centerline Biomedical wraps up pre-clinical study, looks to Series A

Interventional vascular device-focused Centerline Biomedical said today it completed its 1st pre-clinical study evaluating its IOPS endovascular navigation technology and is looking towards a Series-A round of financing to support the device.

The system, based on research from the Cleveland Clinic’s Heart & Vascular Institute, is designed to aid surgeons navigating endovascular aneurism repair procedures, with plans to expand to a variety of different vascular procedures, the Cleveland, Ohio-based company said.

“We are excited about reaching this important milestone as we launch our campaign for Series-A financing. This study is an important step in taking us to our goal of FDA regulatory submission, with market entry targeted in the third quarter of 2017,” prez Dr. Vinod Goel said in prepared remarks.

Data from the pre-clinical study indicated that the system operated as a “precise 3D ‘GPS-like’ tool” for navigation without the necessity of radiation associated with X-ray fluoroscopy.

The company reported that catheters and guidewires were easily visualized on the IOPS display to allow for accurate navigation through arteries.

“Preclinical evaluation of the IOPS system verified the ability to use this navigation system in manipulating through the aorta and its branches in the absence of radiation-inducing fluoroscopy. This will be a game-changer in the era of endovascular therapy,” study lead Dr. Matthew Eagleton of the Cleveland Clinic said in a press release.

The device will reduce the amount of radiation exposure needed during surgery, normally used to guide devices into positions, Centerline said. The Centerline system is completely radiation-free, the company added.

“This highly innovative IOPS technology has the global potential to impact positively the lives of a large number of patients and caregivers alike,” CEO Dr. Jai Gupta said in a prepared statement.

Last August, Centerline Biomedical said it closed a $1.7 million seed investment round of financing to support its vascular surgical navigation system.

The post Centerline Biomedical wraps up pre-clinical study, looks to Series A appeared first on MassDevice.

from MassDevice http://ift.tt/1TYXFyf